However, co-expression of NLK and the LEF1-2A mutant, a constitutively active mutant that cannot be phosphorylated by NLK, completely blocked NLK-mediated changes, suggesting that LEF-1 is a key mediator for NLK signaling in GBM (Figure 3I–3M). The gene discussed is NLK; the disease is glioblastoma.